Avoid common mistakes on your manuscript.
Dear Reader,
Welcome to the final issue of Drugs & Therapy Perspectives for 2022.
As we reach the end of another successful year, we would like to thank all those who have contributed their valuable time and effort to the journal over the past 12 months.
The COVID-19 pandemic has continued to present many challenges and we would like to thank all who have contributed to ensuring the journal has thrived despite the ongoing issues.
We would like to start by thanking the authors of the articles published in Drugs & Therapy Perspectives over the course of 2022. The skill and dedication of these experts is critical to the continued success of the journal.
In 2022, over 70 articles have been published. The most popular of these in terms of downloads from SpringerLink have been:
-
Alfaleh, A., Alkattan, A., Radwan, N. et al. Adverse drug reactions from two COVID-19 vaccines reported in Saudi Arabia. Drugs Ther Perspect 38, 84–92 (2022). https://doi.org/10.1007/s40267-022-00893-y
-
Fenton, C., Keam, S.J. Emerging small molecule antivirals may fit neatly into COVID-19 treatment. Drugs Ther Perspect 38, 112–126 (2022). https://doi.org/10.1007/s40267-022-00897-8
-
Szkiladz, A., Hegner, S. Evaluation of three barrier-type closed system transfer devices using the 2015 NIOSH vapor containment performance draft protocol. Drugs Ther Perspect 38, 177–184 (2022). https://doi.org/10.1007/s40267-022-00905-x
Adis Drug or Device Q&A reviews, which are written by employees of Adis International Ltd./Springer Nature as part of the Adis Drug Review programme, were also very popular, including the following published in 2022:
-
Heo, YA. Oritavancin (KIMYRSA™) in acute bacterial skin and skin structure infections: a profile of its use in the USA. Drugs Ther Perspect 38, 57–63 (2022). https://doi.org/10.1007/s40267-021-00888-1
-
Syed, Y.Y. Dasiglucagon in severe hypoglycemia: a profile of its use. Drugs Ther Perspect 38, 105–111 (2022). https://doi.org/10.1007/s40267-022-00894-x
-
Syed, Y.Y. RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its use. Drugs Ther Perspect 38, 373–381 (2022). https://doi.org/10.1007/s40267-022-00937-3
The quality of published articles is also testament to the diligence of the peer reviewers. We would like to acknowledge the following individuals who acted as reviewers for Drugs & Therapy Perspectives in the last 12 months:
Dag Aarsland, UK
Heba Abdelkader, Egypt
Sola Adeleke, UK
Niyaz Ahmad, Saudi Arabia
Abolfazl Akbari, Islamic Republic of Iran
A.Deniz Akkaya, Turkey
Juan Pablo Alderuccio, USA
Khalidah Alenzi, Saudi Arabia
Eman A. Alghamdi, Saudi Arabia
Abdulaziz Alhazmi, Saudi Arabia
Zainab Ali, Qatar
Abdullah Alismail, USA
Yazed S. Alsowaida, USA
Mohammad Amraee, Islamic Republic of Iran
Kamile Arıkan, Turkey
Carol Armour, Australia
Kurt Ashack, USA
Flora N. Balieva, Norway
Kalyani Barve, India
Kathleen Bennett, Ireland
Uwe Bieri, Switzerland
Jacqueline Birks, UK
Paul A. Bunn, USA
Matthew Burge, Australia
Luca Busetto, Italy
Flavio Cadegiani, Brazil
Michael Camilleri, USA
Anthony M. Casapao, USA
Maria Cerruto, Italy
Shao-Ping Chang, Taiwan, Republic of China
Y. Chen, China
Ann C. Childress, USA
Arrigo F.G. Cicero, Italy
Philip Cohen, USA
Samuele Cortese, UK
Saibal Das, India
Mellar Davis, USA
Francesca De Felice, Italy
Florentina-Silvia F.G. Delli, Greece
Dana DiBenedetti, USA
Hadi Esmaily, Islamic Republic of Iran
Roger Evans, Australia
Justin Faden, USA
Tom Fahey, Ireland
Charlotte Forshay, USA
Brian M. Frier, UK
Jesús Funuyet-Salas, Spain
Silvana Galderisi, Italy
Hamza Garashi, UK
Pere Gascon, Spain
Bilun Gemicioglu, Turkey
Niloofar Ghadamyari, Turkey
Silvia Giovannini, Italy
David Graham, USA
Stephen Grill, USA
Matthew Grissinger, USA
Harm R. Haak, The Netherlands
Swapnil Hiremath, Canada
Alexis E. Horace, USA
Robert H. Howland, USA
Perpetua U. Ibekwe, Nigeria
Ambrose O. Isah, Nigeria
Deidre A. Kelly, UK
Zakir Khan, Turkey
Asmita Priyadarshini Khatiwada, Nepal
Barbara Kiesewetter, Austria
Hiroshi Kitoh, Japan
Haruki Koike, Japan
Dimitra Koumaki, Greece
Lincy Lal, USA
Megan Lam, Canada
Roger D. Lander, USA
Carl J. Lavie, USA
David Liew, Australia
Alisa Likhitsup, USA
Fanxiao Liu, China
Tauqeer H. Mallhi, Saudi Arabia
Jason Margolesky, USA
Tommaso Martino, Italy
Cristiano Matos, Portugal
Daniel Medina Luna, Mexico
Tasneem F. Mohammad, USA
Klaus Mohnike, Germany
Sarah Mousavi, Islamic Republic of Iran
Tinashe Mudzviti, Zimbabwe
Thomas Müller, Germany
Richard Musil, Germany
Mariasanta Napolitano, Italy
Elisa Navarro, USA
Weiyi Ni, USA
Joshua Niznik, USA
Joanna Nowaczyk, Poland
Christophe Orssaud, France
Ranakishor Pelluri, India
Marco Pozzi, Italy
Yash Prashar, India
Jennifer Pruskowski, USA
Olivier Rascol, France
Emily Reeve, Australia
Omar Salamanca, Colombia
Oliver Scherf-Clavel, Germany
Martin Schoen, USA
Leticia Shea, USA
Shatrunajay Shukla, India
Damian Skrypnik, Poland
Meredith Smith, USA
Anshu Srivastava, India
Amit K. Srivastava, India
Thomas P. Stern, USA
Adam Strzelczyk, Germany
Rokeya Sultana, India
Rajesh Tampi, USA
Karina Top, Canada
Jean-Louis Vincent, Belgium
Giuseppe Vita, Italy
Antonio Vitiello, Italy
Sarah E. Vordenberg, USA
Thasia G. Woodworth, USA
Angela Yen Moore, USA
Ichiro Yoshii, Japan
Seyede Raheleh Yousefi, Islamic Republic of Iran
Ismaeel Yunusa, USA
Ge Zhang, Hong Kong, China
We are also very grateful to the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes.
Chris Alderman, Adelaide, SA, Australia [Editors Emeriti]
Richard Day, Sydney, NSW, Australia [Editors Emeriti]
William Frishman, Valhalla, NY, USA [Editors Emeriti]
David J. Greenblatt, Boston, MA, USA [Editors Emeriti]
Hannelore Kreckel, Giessen, Germany [Editors Emeriti]
Howard I. Maibach, San Francisco, CA, USA [Editors Emeriti]
Habeeb Ibrahim Abdul Razach, Riyadh, Saudi Arabia
Abdullah Al Hamid, Riyadh, Saudi Arabia
Yousef A. Alomi, Riyadh, Saudi Arabia
Sabina A. Antoniu, Iaşi, Romania
André RTS Araujo, Portugal
Francisco Araujo, Sevilla, Spain
Antonio Ascione, Napoi, Italy
Mohamed Baraka, Abu Dhabi, United Arab Emirates
Margarida Caramona, Coimbra, Portugal
M. Margarida Castel-Branco, Coimbra, Portugal
Natalia Cebotarenco, Chișinău, Moldova
Surarong Chinwong, Chiang Mai, Thailand
Rui Cruz, Coimbra, Portugal
Paola Maria Cutroneo, Messina, Italy
Shereen Elazzazy, Doha, Qatar
Bogdan Geavlete, Bucharest, Romania
David Hachey, Pocatello, ID, USA
Martina Hahn, Frankfurt am Main, Germany
Syed Shahzad. Hasan, Australia
Satisha Hegde, Puducherry, India
Raquel Herrera Comoglio, Cordoba, Argentina
Abubakar Musa Isa, Dutse, Nigeria
Jimmy Jose, Nizwa, Oman
Gert Laekeman, Leuven, Belgium
Ye Htut Linn, Yangon, Myanmar
Chen ‘Spring’ Liu, Beijing, China
Imran Manji, Eldoret, Kenya
Maria Auxiliadora P. Martins, Belo Horizonte, Brazil
Barbara E. McKenzie, Aberdeen, Scotland
Sanja Mirkov, Auckland, New Zealand
Manuel Morgado, Covilhã, Portugal
Emina Obarcanin, Düsseldorf, Germany
Harikrishnan Parthasarathy, Chennai, India
Florjana Rustemi, Tirane, Albania
Sandeep Saluja, Agra, India
Rima Shah, Rajkot, India
Alok Singh, Raipur, India
Caroline Sirois, Quebec City, QC, Canada
Brian Spoelhof, Charlottesville, VA, USA
Zvi Teitelbaum, Haifa, Israel
Thierry Trenque, Reims, France
Rakshamani Tripathi, Lexington, KY, USA
Kristen K Viktil, Oslo, Norway
Anthony MS. Wang, New Taipei City, Taiwan
William Zirker, Upland, PA, USA
We hope that you have found the articles published throughout 2022 to be both interesting and informative. The editors have appreciated the high quality of content contributed to the journal this year and look forward to keeping you up to date with topical issues in Drugs & Therapy Perspectives in 2023.
We thank you for your continued support.
With best wishes,
Young-A Heo and Zaina Al-Salama
Editors Drugs & Therapy Perspectives
Rights and permissions
About this article
Cite this article
Acknowledgement to Referees. Drugs Ther Perspect 38, 542–545 (2022). https://doi.org/10.1007/s40267-022-00966-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-022-00966-y